BioLineRx Ltd. (BLRX) to Retain KCSA Strategic Communications
Located in Jerusalem, BioLineRx is a publicly-traded company focused on building a portfolio of products for unmet medical needs or with advantages over currently available therapies. Today, BioLineRx took a major step towards prominence with the announcement they have retained KCSA Strategic Communications to direct their U.S. investor relations program. KCSA is a leading New York-based communications firm that intends to deploy a comprehensive investor relations program with the goal of expanding the influence BioLineRx has within the United States. Todd Fromer, whom is a Managing Partner of KCSA will lead the KCSA team and provide strategic counsel on financial…